China NMPA Drug Inspection - Yunnan Yuxi Wangzilong Biopharmaceutical Co., Ltd. - Sanqi tablets
China NMPA drug inspection for Yunnan Yuxi Wangzilong Biopharmaceutical Co., Ltd. published January 18, 2013. Drug: Sanqi tablets. The State Food and Drug Administration (SFDA) of China issued a National Drug Quality Bulletin on January 18, 2013, deta
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Yunnan Yuxi Wangzilong Biopharmaceutical Co., Ltd. published January 18, 2013. Drug: Sanqi tablets. The State Food and Drug Administration (SFDA) of China issued a National Drug Quality Bulletin on January 18, 2013, deta
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox